Homology Medicines Announces Optimized, In Vivo Gene Therapy Candidate for the Treatment of Metachromatic Leukodystrophy

News
2022
2021
Archive

March 10, 2009

SYNOSIA ANNOUNCES SECOND AGREEMENT WITH ROCHE
March 9, 2009

IGENICA APPOINTS DR. MIKE ROTHE AS CEO AFTER CLOSING SERIES A FINANCING
March 3, 2009

ACHAOGEN SIGNS $26.6 MILLION CONTRACT WITH NIAID FOR DEVELOPMENT OF NEW THERAPY TO TREAT RESISTANT STRAINS OF NIAID CATEGORY A AND B PRIORITY PATHOGENS
February 24, 2009

PEARL THERAPEUTICS SECURES $8 MILLION IN DEBT FINANCING
February 9, 2009

ENTREMED PRESENTS INITIAL CLINICAL RESULTS FOR ENMD-2076
February 9, 2009

BIOTECHS BEFRIEND NON-DILUTIVE FUNDS
February 3, 2009

ACHAOGEN INITIATES PHASE 1 TRIAL OF ACHN-490 FOR TREATMENT OF MULTI-DRUG RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS
January 8, 2009

ACHAOGEN RECEIVES ₤4.1 MILLION AWARD FROM THE WELLCOME TRUST TO ADVANCE ITS NEOGLYCOSIDES PORTFOLIO
January 7, 2009

ANAPHORE, INC. ANNOUNCES $25 MILLION SERIES A FINANCING

© 2022 5AM Venture Management LLC